| Abstrakt: |
A report from Tangier, Morocco discusses the impact of HER2-positive breast cancer, which accounts for 20% of all invasive breast cancers. This type of cancer is associated with increased recurrence, a higher risk of brain metastases, and shorter overall survival compared to other types of breast cancer. The report highlights the importance of determining HER2 status for treatment decisions and provides an overview of the techniques used to determine HER2 status. The research emphasizes the need to consider pre-analytical factors and tumor-specific factors that can affect the interpretation of results. [Extracted from the article] |
